HB Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
HB Wealth Management's NVS Position: Q2 2026 in Review
HB Wealth Management increased its Novartis (NVS) stake by 6.8% in Q2 2026, buying an estimated $185K and bringing the position to 19,549 shares worth $3.06M. The position accounts for 0.02% of the portfolio, ranked #371.
HB Wealth Management first reported a position in NVS in Q1 2022 and has held it in 18 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- HB Wealth Management held 19,549 shares of Novartis worth $3.06M as of Q2 2026.
- HB Wealth Management bought 1,237 Novartis shares in Q2 2026, an estimated $185K.
- Novartis made up 0.02% of HB Wealth Management's portfolio in Q2 2026, its #371 holding.
- HB Wealth Management first reported a position in Novartis in Q1 2022 and has held it in 18 quarters since.
- 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.